Hepatitis B reactivation in patients receiving direct-acting antiviral therapy or interferon-based therapy for hepatitis C: A systematic review and meta-analysis

doi:10.3748/wjg.v24.i28.3181

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8532)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series.

Item

Count

PDF

601

HTML

5015

Figures (1-8)

224

Sum=5840

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1048

Download

1644

Sum=2692

Jul 28, 2018 (publication date) through Sep 18, 2024

Times Cited of This Article

Times Cited (32)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Jul 28, 2018; 24(28): 3181-3191
Published online Jul 28, 2018. doi: 10.3748/wjg.v24.i28.3181

Full Size Figure Download Figure

Figure 3 Hepatitis B virus reactivation according to baseline hepatitis B virus DNA level in hepatitis C virus patients with chronic hepatitis B virus infection. Relative risk of hepatitis B virus (HBV) reactivation according to baseline HBV DNA level in hepatitis C virus patients with chronic hepatitis B surface antigen-positive HBV infection.

Citation: Jiang XW, Ye JZ, Li YT, Li LJ. Hepatitis B reactivation in patients receiving direct-acting antiviral therapy or interferon-based therapy for hepatitis C: A systematic review and meta-analysis. World J Gastroenterol 2018; 24(28): 3181-3191
URL: https://www.wjgnet.com/1007-9327/full/v24/i28/3181.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i28.3181